Navigating an Uncertain Regulatory Landscape
PharmExec
FEBRUARY 15, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Sat.Feb 15, 2025
52 
Cabozantinib Extends Survival in RCC Patients with Untreated Brain Metastases
Pharmacy Times
FEBRUARY 15, 2025
Data from the phase 2 CABRAMET trial suggests the potential of cabozantinib for treatment of brain metastases from renal cell carcinoma (RCC).
Join 11,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Opinion: A physician and author’s 1984 tribute to the NIH feels all the more valuable today
STAT
FEBRUARY 15, 2025
Every couple of weeks I travel to Princeton University to do archival research for a planned biography of the physician-humanist Lewis Thomas (1913-1993). Thomas was president of Memorial Sloan-Kettering Cancer Center, author of “ The Lives of a Cell ,” and winner of two National Book Awards and a 1989 Lasker Prize , which heralded him as “the poet laureate of 20th Century medicine.
Refining CRS and ICANS Management in CAR T-Cell Therapy: Understanding Evolving Diagnostic Criteria and Treatment Strategies
Pharmacy Times
FEBRUARY 15, 2025
C. Brooke Adams, PharmD, BCOP, discusses the evolving diagnostic criteria and management strategies for cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) in CAR T-cell therapy, highlighting advances in toxicity prevention and treatment selection.
Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Trump administration lays off FDA employees
STAT
FEBRUARY 15, 2025
WASHINGTON — The Trump administration terminated employees at the Food and Drug Administration on Saturday night, three sources told STAT. It wasn’t immediately clear how many FDA employees were affected, nor how many parts of the agency may be involved. Some of those cut worked in the FDA’s Center for Devices and Radiological Health, one of the people said.
Etranacogene Dezaparvovec-drlb Delivers Sustained, Increased Bleed Protection Compared With Prophylaxis in Hemophilia B
Pharmacy Times
FEBRUARY 15, 2025
A one-time infusion of etranacogene dezaparvovec-drlb led to sustained bleeding control and a reduction in factor IX prophylaxis in patients with hemophilia B.
Let's personalize your content